This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: The Innovations of Nidhal Selmi
Introduction
Nidhal Selmi is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on amido heteroaromatic compounds. His research focuses on compounds that have potential applications in treating various diseases, including liver disease.
Latest Patents
Nidhal Selmi holds 1 patent for his invention related to amido heteroaromatic compounds. The patent specification details the compounds of Formula (I) and their pharmaceutically acceptable salts. It also outlines the processes and intermediates used for their preparation, as well as the pharmaceutical compositions containing these compounds.
Career Highlights
Nidhal Selmi is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to the development of innovative treatments that address critical health issues.
Collaborations
Throughout his career, Nidhal has collaborated with several talented individuals, including Daniel Tor Pettersen and Stéphanie Marcelle Gueret. These collaborations have enhanced his research and contributed to the advancement of pharmaceutical science.
Conclusion
Nidhal Selmi's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions to the development of amido heteroaromatic compounds highlight the importance of research in creating effective treatments for diseases.